Cargando…
Failure of leucocyte-adherence-inhibition assays to discriminate between benign and malignant breast diseases.
Autores principales: | Vose, B. M., Hughes, R., Bazill, G. W. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1979
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2010137/ https://www.ncbi.nlm.nih.gov/pubmed/393293 |
Ejemplares similares
-
Anti-tumour immunity in malignant melanoma assay by tube leucocyte adherence inhibition.
por: Marti, J. H., et al.
Publicado: (1976) -
Expression of major histocompatibility antigens and leucocyte infiltration in benign and malignant human breast disease.
por: Whitwell, H. L., et al.
Publicado: (1984) -
The natural history of antitumour immunity in human breast cancer assayed by tube leucocyte adherence inhibition.
por: Lopez, M., et al.
Publicado: (1978) -
Evaluation of leucocyte adherence inhibition in hepatocellular carcinoma.
por: Dusheiko, G. M., et al.
Publicado: (1979) -
A study of false positive and negative responses in the tube leucocyte adherence inhibition (tube LAI) assay.
por: O'Connor, R., et al.
Publicado: (1978)